ANAVEX
Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery SIGMACEPTOR™ platform. The Anavex portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. The company’s lead drug candidate for Alzheimer’s Disease (AD), ANAVEX 2-73, has successfully completed a Phase 1 single ascending dose (SAD) clinical trial. The company has also started scale-up manufacturing for ANAVEX 1-41, its second lead compound, targeting depression and AD. With sufficient quantities of ANAVEX 1-41 in hand, the company will be in a position to advance the program and begin preclinical studies on large animals in the near term.
ANAVEX
Industry:
Biopharma Biotechnology Health Care Manufacturing Therapeutics
Founded:
2006-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.anavex.com
Total Employee:
1+
Status:
Active
Contact:
14164890092
Email Addresses:
[email protected]
Total Funding:
62.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Sitelinks Search Box GStatic Google Static Content COVID-19 Sectigo SSL
Similar Organizations
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Anavex
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-06 | Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer |
Official Site Inspections
http://www.anavex.com Semrush global rank: 1.81 M Semrush visits lastest month: 12.54 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Anavex"
Investors - Anavex Life Sciences
Learn more about how the team at Anavex Life Sciences strive to produce sustained strong performance and shareholder value.See details»
Steven P. Neilson - Vice President Clinical Operations at Anavex Life ...
Steven P. has held various senior roles and has a strong background in clinical operations. Their most recent position was as the Vice President of Clinical Operations at Anavex Life Sciences, …See details»
About Us | Anavex Life Sciences
Anavex Life Sciences Corp. (Nasdaq: AVXL) is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments.See details»
Anavex Life Sciences - Leadership Team | The Org
The Leadership Team at Anavex Life Sciences is responsible for setting the strategic direction of the company, overseeing clinical development, regulatory compliance, and operational efficiency.See details»
Anavex - Crunchbase Company Profile & Funding
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.See details»
Corporate Governance - Anavex Life Sciences
Corporate governance documents available for download and review.See details»
Anavex - Contacts, Employees, Board Members, Advisors & Alumni
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.See details»
Senior Vice President, CMC at Anavex Life Sciences - The …
Selvey's most recent position is as the Senior Vice President of CMC at Anavex Life Sciences, which they began in 2018 and continues to hold. Alani Selvey pursued a Ph.D. in Physical Chemistry at Duke University, although the exact start and end …See details»
Nell Rebowe - Director of Business Development at Anavex Life
View Nell Rebowe at Anavex Life Sciences on The OrgSee details»
Anavex Life Sciences : Corporate Presentation July 2025
Jul 23, 2025 Anavex Life Sciences Corp. published this content on July 23, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), …See details»
Anavex Life Sciences Org Chart + Executive Team - The Official Board
The org chart of Anavex Life Sciences contains its 12 main executives including Christopher Missling and Terrie Kellmeyer.See details»
Anavex Life Sciences - Regulatory Affairs and Strategy | The Org
The Regulatory Affairs and Strategy team at Anavex Life Sciences plays a crucial role in guiding the development of therapeutics through regulatory processes, ensuring compliance with health …See details»
Investor Material - Anavex Life Sciences
Dec 23, 2024 At Anavex Life Sciences, we strive to produce sustained strong performance and shareholder value.See details»
Anavex Life Sciences : Corporate Presentation July 2025
Jul 23, 2025 Cumulative costs of Alzheimer's and dementia care from 2015 to 2050 PEOPLE LIVING WITH DEMENTIA AROUND THE WORLD Source: World Alzheimer's Report 4 Anavex …See details»
Anavex Life Sciences - The Org
Anavex Life Sciences Corp. (www.anavex.com) is a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodevelopmental and …See details»
Anavex Life Sciences - Teams | The Org
Explore teams at Anavex Life Sciences. View team members, open roles, and company details.See details»
Anavex Life Sciences Corp. Reports Q1 Fiscal 2025 Financial ... - Nasdaq
Feb 12, 2025 Anavex Life Sciences reports Q1 2025 financial results and hosts a webcast discussing advancements in Alzheimer’s treatment.See details»
Anavex Life Sciences Corp. - Drug pipelines, Patents ... - Patsnap
Jul 6, 2025 Explore Anavex Life Sciences Corp. with its drug pipeline, therapeutic area, technology platform, 14 clinical trials, 136 news, and 9 literature, Disease Domain:Nervous System Diseases, …See details»
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health …
Feb 24, 2025 Anavex Life Sciences Corp. (Nasdaq: AVXL) is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of …See details»
Anavex Life Sciences Management Team | Org Chart - RocketReach
The Anavex Life Sciences management team includes Christopher Missling (President and CEO), Emma Smith (Human Resources Manager), and Terrie Kellmeyer (Senior Vice President Clinical …See details»